US seeks up to $18.1B from Purdue Pharma

More short articles on drug store:3 retail pharma giants disclose data breaches from break-ins: What to knowAmazons PillPack partners with New Jersey insurance company, Prime TherapeuticsAmerican females most likely than males to skip medication due to cost, study finds.

The Justice Department is looking at whether Purdue Pharma provided kickbacks to physicians and pharmacies to encourage them to recommend and give more OxyContin and whether the drugmaker moved money to hide cash from creditors..

Maia Anderson –
Wednesday, August 5th, 2020
Print|Email.

The Justice Department valued the civil claims at $2.8 billion, which might be tripled, according to the Journal. If Purdue Pharma is convicted on criminal charges, the government stated it would seek a $6.2 billion fine and forfeiture of possibly $3.5 billion more..

The Justice Department decreased to comment to the Journal..

New court filings seen by the Journal reveal that federal prosecutors are examining whether Purdue Pharmas marketing and distribution of opioids breached criminal statutes, consisting of anti-kickback laws, misbranding under the Food, Drug and Cosmetic Act and conspiracy.

The U.S. Justice Department is seeking as much as $18.1 billion from Purdue Pharma over its marketing and distribution of opioids, The Wall Street Journal reported..

Check out the complete article here.

A representative for Purdue Pharma told the Journal the company is in discussions with the Justice Department to fix civil and criminal examinations and that it had no more comment..

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.